Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination-Reference-Cited by-同舟云学术

Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination

Published:2023-05 Issue:5 Volume:9 Page:e16233
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Wang Bin,Li Zhiling^ORCID

Funder

Guangdong Science and Technology Department

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference33 articles.

1. The role of AMH in the pathophysiology of polycystic ovarian syndrome;Garg;Reprod. Biomed. Online,2016

2. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome;Legro;N. Engl. J. Med.,2014

3. Rotterdam, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome;Fertil. Steril.,2004

4. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome;Teede;Med. J. Aust.,2018

5. Polycystic ovary syndrome;Joham;Lancet Diabetes Endocrinol.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of birth outcomes, congenital anomalies and neonatal complications of singletons born to infertile women treated with letrozole: A retrospective cohort study;Experimental and Therapeutic Medicine;2024-05-31

2. Mechanisms and Target Parameters in Relation to Polycystic Ovary Syndrome and Physical Exercise: Focus on the Master Triad of Hormonal Changes, Oxidative Stress, and Inflammation;Biomedicines;2024-03-01